Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01358331
Show Display Options
Rank Status Study
1 Terminated A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001)
Condition: Tumor, Solid
Intervention: Drug: MK-8353

Indicates status has not been verified in more than two years